Stem Cell treatment in Diabetes

Diabetes management may benefit from stem cell therapy. In order to replace damaged or defective cells in diabetic patients, researchers are investigating the capacity of stem cells to develop into cells that produce insulin. The regenerative potential of many stem cell types, such as adult stem cells, induced pluripotent stem cells, and embryonic stem cells, is being investigated. Early clinical trials have produced good outcomes in terms of enhancing insulin production and glycaemic management. Before stem cell-based therapies for diabetes may be extensively used in clinical practise, additional study is required to confirm their safety, long-term efficacy, and scalability.

    Related Conference of Stem Cell treatment in Diabetes

    September 09-10, 2024

    7th Annual Meeting on Diabetes and Endocrinology

    Paris, France
    September 09-10, 2024

    4th European Endocrinology and Diabetes Congress

    Paris, France
    September 25-26, 2024

    5th World Summit on Diabetes Expo

    Rome, Italy
    October 14-15, 2024

    3rd International Summit on Hormonal Disorders

    Madrid, Spain
    November 22-23, 2024

    20th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands

    Stem Cell treatment in Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in